Wingesic MR Tablet is a combination medication containing Chlorzoxazone 250 mg, Diclofenac 50 mg, and Paracetamol 325 mg, formulated to provide effective relief from musculoskeletal pain and inflammation. Chlorzoxazone acts as a centrally acting muscle relaxant, alleviating muscle spasms and stiffness by depressing the central nervous system. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol contributes additional analgesic and antipyretic properties through central inhibition of prostaglandin synthesis, enhancing overall pain relief. This combination is particularly useful in managing acute musculoskeletal conditions such as strains, sprains, and back pain, where both muscle spasm and inflammation are present. Wingesic MR Tablet should be used under medical supervision, considering contraindications such as hypersensitivity to any component, active gastrointestinal ulcers, severe hepatic or renal impairment, and cardiovascular risks associated with NSAIDs. Common adverse effects may include gastrointestinal discomfort, dizziness, or allergic reactions. Patients are advised to adhere to prescribed dosages and report any unusual symptoms promptly. Wingesic MR Tablet offers a comprehensive approach to pain management by targeting multiple pathways involved in musculoskeletal pain and inflammation.